Nam-Joon Cho is Nanyang Associate Professor in the School of Materials Science and Engineering at Nanyang Technological University in Singapore and Deputy Director of the Nanyang Institute of Technology in Health and Medicine. In addition, he is a Principal Investigator at the Singapore-MIT Alliance for Research and Technology. His group’s research focuses on engineering approaches to solve important biomedical problems and to translate these capabilities into practical applications for global health. Dr. Cho’s scientific work has been highlighted by international media organizations such as Reuters, CNBC, and Businessweek, and is leading to major breakthroughs for the treatment of deadly pathogens. He has identified novel classes of antiviral drugs to treat hepatitis C and dengue virus infections. Dr. Cho’s team is now actively working to examine the causes and consequences of infectious diseases in order to provide improved diagnostic and therapeutic interventions. Dr. Cho also leads a multi-institution tissue engineering collaboration involving NTU and the Stanford University School of Medicine, which focuses on developing an artificial liver platform for regenerative medicine applications. He is a graduate of Stanford University and the University of California, Berkeley.
